Stage I NSCLC: the extent of surgical resection needed, or, better yet, radiotherapy? Source: International Congress 2017 – Rational strategies for specific treatment situations in lung cancer Year: 2017
Can we still justify pneumonectomy following induction chemotherapy? Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006
Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT). Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Prodromal face of a study: High dose rate endobronchial brachytherapy (HDERB) as a first step introductory treatment of a multimodality therapy approach in non operable NSCLC with endobronchial obstruction Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Combined endosonographic staging followed by cervical mediastinoscopy in the real world, do we still need both? Source: Annual Congress 2012 - EBUS-TBNA: a never ending story Year: 2012
A multimodality treatment approach to post transplant airway stenosis Source: Annual Congress 2011 - To stent or not to stent: interventional bronchoscopy Year: 2011
Estimation of the mediastinal involvement probability in lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy? Source: Eur Respir J 2002; 20: Suppl. 38, 186s Year: 2002
Delayed desobstruction techniques Source: Annual Congress 2006 - PG2 - Interventional pulmonology: theory and practice Year: 2006
Long time survival after resection for multiple primary lung cancers. A population-based study Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005
Evaluation of the utility of the VRIxp O-plan (vibration response imaging operation planning) in the prediction of pulmonary function after lung surgical resection Source: Annual Congress 2009 - Lung function testing: between spirometry and structured light plethysmography Year: 2009
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Source: Eur Respir J 2009; 34: 17-41 Year: 2009
Decreasing the need for upfront surgery: new imaging techniques and endoscopic staging Source: Annual Congress 2010 - Selection criteria in lung cancer surgery: what really changed? Year: 2010
SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020 Year: 2020
PET-CT, NSCLC staging and surgery: an audit of current experience Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008
A higher-risk patient with a choice between stereotactic radiotherapy and surgery Source: International Congress 2019 – Lung cancer Grand Round Year: 2019
Pushing the limits, real benefit for the patient ? – a curative treatment approach in an unfit lung cancer patient Source: International Congress 2017 – GR2 Lung Cancer Grand Round Year: 2017